论文部分内容阅读
目的:探讨大肝癌病人肝切除术后和肝切除术后联合肝动脉化疗栓塞(TACE)综合治疗大肝癌中长期生存率。方法:回顾性分析360例肝细胞癌病人本院行肝切除术后的长期疗效及生存状况,其中进行单纯手术治疗185例,手术联合TACE综合治疗组175例。结果:肝癌病人单纯手术治疗1、3、5年生存率分别为71.7%、59.3%、35.7%,术后联合TACE综合治疗1、3、5年生存率分别为82.5%、71.3%、56.7%。结论:手术联合TACE综合治疗方案对于大肝癌病人具有更好的治疗效果,在提高患者远期生存状况方面更优。
Objective: To investigate the long-term survival rate of large hepatocellular carcinoma after hepatectomy and hepatectomy combined with transcatheter arterial chemoembolization (TACE) in patients with large hepatocellular carcinoma. Methods: A retrospective analysis of 360 patients with hepatocellular carcinoma in our hospital long-term efficacy and survival after liver resection, including 185 cases of simple surgical treatment, surgery and TACE combined treatment group of 175 cases. Results The 1-, 3-, 5-year survival rates of hepatocellular carcinoma patients treated with TACE alone were 71.7%, 59.3% and 35.7%, respectively. The 1,3 and 5-year survival rates after combined TACE and TACE were 82.5%, 71.3% and 56.7% . Conclusion: The combined operation of TACE and TACE has a better therapeutic effect on patients with large hepatocellular carcinoma and is better in improving the long-term survival of patients.